Laporte M - Search Results

1

Uptake, discontinuation, and continuation rate of long-acting contraceptive methods when offered at no cost in Campinas, Brazil.

Laporte M, Marcelino AC, Pereira PDC, Espejo-Arce X, Juliato CT, Bahamondes L. Laporte M, et al. Contraception. 2024 Apr;132:110363. doi: 10.1016/j.contraception.2024.110363. Epub 2024 Jan 7. Contraception. 2024. PMID: 38195047

2

Postplacental placement of intrauterine devices: A randomized clinical trial.

Laporte M, Marangoni M Jr, Surita F, Juliato CT, Miadaira M, Bahamondes L. Laporte M, et al. Contraception. 2020 Mar;101(3):153-158. doi: 10.1016/j.contraception.2019.12.006. Epub 2020 Jan 9. Contraception. 2020. PMID: 31927027 Clinical Trial.

3

Evaluation of clinical performance when intrauterine devices are inserted by different categories of healthcare professional.

Laporte M, Becerra A, Castro L, Veiga N Jr, Espejo-Arce X, Bahamondes L. Laporte M, et al. Int J Gynaecol Obstet. 2021 Feb;152(2):196-201. doi: 10.1002/ijgo.13396. Epub 2020 Oct 19. Int J Gynaecol Obstet. 2021. PMID: 32981045

4

Maternal health among Venezuelan women migrants at the border of Brazil.

Bahamondes L, Laporte M, Margatho D, de Amorim HSF, Brasil C, Charles CM, Becerra A, Hidalgo MM. Bahamondes L, et al. Among authors: laporte m. BMC Public Health. 2020 Nov 23;20(1):1771. doi: 10.1186/s12889-020-09912-x. BMC Public Health. 2020. PMID: 33228642 Free PMC article. Review.

5

One-year follow up on post-placental IUD insertion: A randomized clinical trial.

Marangoni M Jr, Laporte M, Surita F, Kraft MB, Bahamondes L, Juliato CRT. Marangoni M Jr, et al. Among authors: laporte m. Acta Obstet Gynecol Scand. 2021 Apr;100(4):596-603. doi: 10.1111/aogs.14081. Epub 2021 Mar 16. Acta Obstet Gynecol Scand. 2021. PMID: 33421091 Free article. Clinical Trial.

6

Major differences in the characteristics of users of the copper intrauterine device or levonorgestrel intrauterine system at a clinic in Campinas, Brazil.

Laporte M, Metelus S, Ali M, Bahamondes L. Laporte M, et al. Int J Gynaecol Obstet. 2022 Feb;156(2):240-246. doi: 10.1002/ijgo.13716. Epub 2021 May 6. Int J Gynaecol Obstet. 2022. PMID: 33872406

7

Reasons reported by women for choosing the levonorgestrel intrauterine system as a contraceptive method.

Laporte M, Charles CM, Metelus S, Peloggia A, Paez GO, Juliato CT, Bahamondes L. Laporte M, et al. Int J Gynaecol Obstet. 2022 Sep;158(3):700-704. doi: 10.1002/ijgo.14062. Epub 2021 Dec 23. Int J Gynaecol Obstet. 2022. PMID: 34862968

8

Perspectives of health care providers regarding the levonorgestrel-releasing intrauterine system.

Laporte M, Peloggia A, Marcelino AC, de Carvalho LS, Bahamondes L. Laporte M, et al. Eur J Contracept Reprod Health Care. 2022 Jun;27(3):208-211. doi: 10.1080/13625187.2021.2010043. Epub 2021 Dec 6. Eur J Contracept Reprod Health Care. 2022. PMID: 34870546

9

Reasons for satisfaction with the use of the 52-mg levonorgestrel intrauterine system.

Laporte M, Charles CM, Metelus S, Souza RB, Peloggia A, Bahamondes L. Laporte M, et al. Int J Gynaecol Obstet. 2022 Nov;159(2):577-582. doi: 10.1002/ijgo.14214. Epub 2022 Apr 22. Int J Gynaecol Obstet. 2022. PMID: 35396862

10

Single-visit long-acting reversible contraception provision and pregnancy rates within 3 months.

Manhiça SI, Bahamondes L, Laporte M, Anjos F, Viscola M, Garcia E, Paiva LC. Manhiça SI, et al. Among authors: laporte m. Int J Gynaecol Obstet. 2023 Jun;161(3):1028-1032. doi: 10.1002/ijgo.14630. Epub 2022 Dec 26. Int J Gynaecol Obstet. 2023. PMID: 36527255

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

373 results

Search Page